KRAS and hepatocellular carcinoma: KRAS‐mutant HCC cells exhibit upregulated Nrf2, a master regulator of ferroptosis resistance through many ferroptosis related metabolic processes, such as SLC7A11‐mediated cystine uptake and GPX4‐dependent lipid peroxide detoxification.